Hugo_Symbol	Entrez_Gene_Id	Center	NCBI_Build	Chromosome	Start_position	End_position	Strand	Variant_Classification	Variant_Type	Reference_Allele	Tumor_Seq_Allele1	Tumor_Seq_Allele2	dbSNP_RS	dbSNP_Val_Status	Tumor_Sample_Barcode	Matched_Norm_Sample_Barcode	Match_Norm_Seq_Allele1	Match_Norm_Seq_Allele2	Tumor_Validation_Allele1	Tumor_Validation_Allele2	Match_Norm_Validation_Allele1	Match_Norm_Validation_Allele2	Verification_Status	Validation_Status	Mutation_Status	Sequencing_Phase	Sequence_Source	Validation_Method	Score	BAM_file	Sequencer	Tumor_Sample_UUID	Matched_Norm_Sample_UUID	Genome_Change	Annotation_Transcript	Transcript_Strand	Transcript_Exon	Transcript_Position	cDNA_Change	Codon_Change	Protein_Change	Other_Transcripts	Refseq_mRNA_Id	Refseq_prot_Id	SwissProt_acc_Id	SwissProt_entry_Id	Description	UniProt_AApos	UniProt_Region	UniProt_Site	UniProt_Natural_Variations	UniProt_Experimental_Info	GO_Biological_Process	GO_Cellular_Component	GO_Molecular_Function	COSMIC_overlapping_mutations	COSMIC_fusion_genes	COSMIC_tissue_types_affected	COSMIC_total_alterations_in_gene	Tumorscape_Amplification_Peaks	Tumorscape_Deletion_Peaks	TCGAscape_Amplification_Peaks	TCGAscape_Deletion_Peaks	DrugBank	ref_context	gc_content	CCLE_ONCOMAP_overlapping_mutations	CCLE_ONCOMAP_total_mutations_in_gene	CGC_Mutation_Type	CGC_Translocation_Partner	CGC_Tumor_Types_Somatic	CGC_Tumor_Types_Germline	CGC_Other_Diseases	DNARepairGenes_Role	FamilialCancerDatabase_Syndromes	MUTSIG_Published_Results	OREGANNO_ID	OREGANNO_Values	i_1000Genome_AA	i_1000Genome_AC	i_1000Genome_AF	i_1000Genome_AFR_AF	i_1000Genome_AMR_AF	i_1000Genome_AN	i_1000Genome_ASN_AF	i_1000Genome_AVGPOST	i_1000Genome_CIEND	i_1000Genome_CIPOS	i_1000Genome_END	i_1000Genome_ERATE	i_1000Genome_EUR_AF	i_1000Genome_HOMLEN	i_1000Genome_HOMSEQ	i_1000Genome_LDAF	i_1000Genome_RSQ	i_1000Genome_SNPSOURCE	i_1000Genome_SVLEN	i_1000Genome_SVTYPE	i_1000Genome_THETA	i_1000Genome_VT	i_ACHILLES_Lineage_Results_Top_Genes	i_CGC_CancerGermlineMut	i_CGC_CancerMolecularGenetics	i_CGC_CancerSomaticMut	i_CGC_CancerSyndrome	i_CGC_Chr	i_CGC_ChrBand	i_CGC_GeneID	i_CGC_Name	i_CGC_OtherGermlineMut	i_CGC_TissueType	i_COSMIC_n_overlapping_mutations	i_COSMIC_overlapping_mutation_descriptions	i_COSMIC_overlapping_primary_sites	i_ClinVar_ASSEMBLY	i_ClinVar_HGMD_ID	i_ClinVar_SYM	i_ClinVar_TYPE	i_ClinVar_rs	i_ESP_AA	i_ESP_AAC	i_ESP_AA_AC	i_ESP_AA_AGE	i_ESP_AA_GTC	i_ESP_AvgAAsampleReadDepth	i_ESP_AvgEAsampleReadDepth	i_ESP_AvgSampleReadDepth	i_ESP_CA	i_ESP_CDP	i_ESP_CG	i_ESP_CP	i_ESP_Chromosome	i_ESP_DBSNP	i_ESP_DP	i_ESP_EA_AC	i_ESP_EA_AGE	i_ESP_EA_GTC	i_ESP_EXOME_CHIP	i_ESP_FG	i_ESP_GL	i_ESP_GM	i_ESP_GS	i_ESP_GTC	i_ESP_GTS	i_ESP_GWAS_PUBMED	i_ESP_MAF	i_ESP_PH	i_ESP_PP	i_ESP_Position	i_ESP_TAC	i_ESP_TotalAAsamplesCovered	i_ESP_TotalEAsamplesCovered	i_ESP_TotalSamplesCovered	i_Ensembl_so_accession	i_Ensembl_so_term	i_Familial_Cancer_Genes_Reference	i_Familial_Cancer_Genes_Synonym	i_HGNC_EnsemblGeneID	i_HGNC_HGNCID	i_HGNC_RefSeqIDs	i_HGNC_Status	i_HGNC_UCSCIDsuppliedbyUCSC	i_ORegAnno_bin	i_UniProt_alt_uniprot_accessions	i_annotation_transcript	i_build	i_ccds_id	i_dbNSFP_1000Gp1_AC	i_dbNSFP_1000Gp1_AF	i_dbNSFP_1000Gp1_AFR_AC	i_dbNSFP_1000Gp1_AFR_AF	i_dbNSFP_1000Gp1_AMR_AC	i_dbNSFP_1000Gp1_AMR_AF	i_dbNSFP_1000Gp1_ASN_AC	i_dbNSFP_1000Gp1_ASN_AF	i_dbNSFP_1000Gp1_EUR_AC	i_dbNSFP_1000Gp1_EUR_AF	i_dbNSFP_Ancestral_allele	i_dbNSFP_CADD_phred	i_dbNSFP_CADD_raw	i_dbNSFP_CADD_raw_rankscore	i_dbNSFP_ESP6500_AA_AF	i_dbNSFP_ESP6500_EA_AF	i_dbNSFP_Ensembl_geneid	i_dbNSFP_Ensembl_transcriptid	i_dbNSFP_FATHMM_pred	i_dbNSFP_FATHMM_rankscore	i_dbNSFP_FATHMM_score	i_dbNSFP_GERP_NR	i_dbNSFP_GERP_RS	i_dbNSFP_GERP_RS_rankscore	i_dbNSFP_Interpro_domain	i_dbNSFP_LRT_Omega	i_dbNSFP_LRT_converted_rankscore	i_dbNSFP_LRT_pred	i_dbNSFP_LRT_score	i_dbNSFP_LR_pred	i_dbNSFP_LR_rankscore	i_dbNSFP_LR_score	i_dbNSFP_MutationAssessor_pred	i_dbNSFP_MutationAssessor_rankscore	i_dbNSFP_MutationAssessor_score	i_dbNSFP_MutationTaster_converted_rankscore	i_dbNSFP_MutationTaster_pred	i_dbNSFP_MutationTaster_score	i_dbNSFP_Polyphen2_HDIV_pred	i_dbNSFP_Polyphen2_HDIV_rankscore	i_dbNSFP_Polyphen2_HDIV_score	i_dbNSFP_Polyphen2_HVAR_pred	i_dbNSFP_Polyphen2_HVAR_rankscore	i_dbNSFP_Polyphen2_HVAR_score	i_dbNSFP_RadialSVM_pred	i_dbNSFP_RadialSVM_rankscore	i_dbNSFP_RadialSVM_score	i_dbNSFP_Reliability_index	i_dbNSFP_SIFT_converted_rankscore	i_dbNSFP_SIFT_pred	i_dbNSFP_SIFT_score	i_dbNSFP_SLR_test_statistic	i_dbNSFP_SiPhy_29way_logOdds	i_dbNSFP_SiPhy_29way_logOdds_rankscore	i_dbNSFP_SiPhy_29way_pi	i_dbNSFP_UniSNP_ids	i_dbNSFP_Uniprot_aapos	i_dbNSFP_Uniprot_acc	i_dbNSFP_Uniprot_id	i_dbNSFP_aaalt	i_dbNSFP_aapos	i_dbNSFP_aapos_FATHMM	i_dbNSFP_aapos_SIFT	i_dbNSFP_aaref	i_dbNSFP_cds_strand	i_dbNSFP_codonpos	i_dbNSFP_folddegenerate	i_dbNSFP_genename	i_dbNSFP_hg18_pos1coor	i_dbNSFP_phastCons100way_vertebrate	i_dbNSFP_phastCons100way_vertebrate_rankscore	i_dbNSFP_phastCons46way_placental	i_dbNSFP_phastCons46way_placental_rankscore	i_dbNSFP_phastCons46way_primate	i_dbNSFP_phastCons46way_primate_rankscore	i_dbNSFP_phyloP100way_vertebrate	i_dbNSFP_phyloP100way_vertebrate_rankscore	i_dbNSFP_phyloP46way_placental	i_dbNSFP_phyloP46way_placental_rankscore	i_dbNSFP_phyloP46way_primate	i_dbNSFP_phyloP46way_primate_rankscore	i_dbNSFP_refcodon	i_gencode_transcript_name	i_gencode_transcript_status	i_gencode_transcript_tags	i_gencode_transcript_type	i_gene_id	i_gene_type	i_havana_transcript	i_init_t_lod	i_judgement	i_secondary_variant_classification	i_strand	i_t_lod_fstar	i_tumor_f	t_alt_count	t_ref_count	validation_alt_allele	validation_method	validation_status	validation_tumor_sample	validation_judgement_targeted	validation_power_targeted	validation_tumor_alt_count_targeted	validation_tumor_ref_count_targeted	validation_normal_alt_count_targeted	validation_normal_ref_count_targeted	discovery_tumor_alt_count_targeted	discovery_tumor_ref_count_targeted	discovery_normal_alt_count_targeted	discovery_normal_ref_count_targeted	min_val_count_targeted	validation_status_consensus
PIK3CA	5290	broad.mit.edu	37	3	178952152	178952152	+	Nonstop_Mutation	SNP	A	A	G			GBM-TCGA-32-1979-Tumor-SM-1Y49G	GBM-TCGA-32-1979-Normal-SM-1Y49B	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid	Somatic	Phase_I	WXS	none,targeted,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-32-1979-Tumor-SM-1Y49G	GBM-TCGA-32-1979-Normal-SM-1Y49B	g.chr3:178952152A>G	ENST00000263967.3	+	21	3364	c.3207A>G	c.(3205-3207)tgA>tgG	p.*1069W		NM_006218.2	NP_006209.2	P42336	PK3CA_HUMAN	phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha	0		NA			epidermal growth factor receptor signaling pathway|fibroblast growth factor receptor signaling pathway|insulin receptor signaling pathway|leukocyte migration|nerve growth factor receptor signaling pathway|phosphatidylinositol-mediated signaling|platelet activation|T cell costimulation|T cell receptor signaling pathway		1-phosphatidylinositol-3-kinase activity|ATP binding|phosphatidylinositol-4,5-bisphosphate 3-kinase activity	p.*1069_*1069insWKDN*(3)		NS(16)|autonomic_ganglia(4)|biliary_tract(22)|bone(1)|breast(2150)|central_nervous_system(110)|cervix(33)|endometrium(473)|eye(1)|haematopoietic_and_lymphoid_tissue(35)|kidney(14)|large_intestine(1202)|liver(42)|lung(202)|meninges(1)|oesophagus(28)|ovary(235)|pancreas(17)|penis(8)|pituitary(12)|prostate(10)|skin(155)|small_intestine(1)|soft_tissue(18)|stomach(121)|thyroid(80)|upper_aerodigestive_tract(70)|urinary_tract(208)	5269	all_cancers(143;1.19e-17)|Ovarian(172;0.00769)|Breast(254;0.155)		OV - Ovarian serous cystadenocarcinoma(80;9.59e-28)|GBM - Glioblastoma multiforme(14;0.003)|BRCA - Breast invasive adenocarcinoma(182;0.0282)			CATTGAACTGAAAAGATAACT	0.393	NA	57	Mis		"""colorectal, gastric, gliobastoma, breast"""					HNSCC(19;0.045)|TSP Lung(28;0.18)	NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA		Colon(199;1504 1750 3362 26421 31210 32040)		Dom	yes		3	3q26.3	5290	"""phosphoinositide-3-kinase, catalytic, alpha polypeptide"""		"""E, O"""	3	Insertion - In frame(3)	endometrium(2)|ovary(1)	NA	NA	NA	NA	NA						79	71	74	NA		NA	NA	3		NA											NA				178952152		1897	4138	6035	SO:0001578	stop_lost			ENSG00000121879	HGNC:8975		Approved	uc003fjk.3	NA	Q14CW1|Q99762	ENST00000263967.3	37	CCDS43171.1	.	.	.	.	.	.	.	.	.	.	A	13.82	2.351538	0.41700	.	.	ENSG00000121879	ENST00000263967	.	.	.	5.94	5.94	0.96194	.	.	.	.	.	.	.	.	.	.	.	0.20563	N	0.999881	.	.	.	.	.	.	.	.	.	.	.	.	.	.	16.3945	0.83586	1.0:0.0:0.0:0.0	.	.	.	.	W	1069	.	.	X	+	3	0	PIK3CA	180434846	1.000000	0.71417	0.971000	0.41717	0.917000	0.54804	8.526000	0.90588	2.265000	0.75225	0.482000	0.46254	TGA	PIK3CA-001	KNOWN	basic|exp_conf|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000348409.2	20.54577	KEEP		+	20.869614	0.352941	6	11	---	---	---	---	1	1	137	270	0	339	7	14	0	59	2	TP
GABRB2	0	broad.mit.edu	37	5	160721114	160721114	+	Missense_Mutation	SNP	C	C	T			GBM-TCGA-32-1979-Tumor-SM-1Y49G	GBM-TCGA-32-1979-Normal-SM-1Y49B	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid	Somatic	Phase_I	WXS	none,targeted,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-32-1979-Tumor-SM-1Y49G	GBM-TCGA-32-1979-Normal-SM-1Y49B	g.chr5:160721114C>T	ENST00000274547.2	-	11	1730	c.1513G>A	c.(1513-1515)Gtc>Atc	p.V505I	GABRB2_ENST00000520240.1_Missense_Mutation_p.V467I|GABRB2_ENST00000393959.1_Missense_Mutation_p.V505I|GABRB2_ENST00000517901.1_Missense_Mutation_p.V404I|GABRB2_ENST00000517547.1_Missense_Mutation_p.V307I|GABRB2_ENST00000353437.6_Missense_Mutation_p.V467I	NM_000813.2|NM_021911.2	NP_000804.1|NP_068711.1	P47870	GBRB2_HUMAN	gamma-aminobutyric acid (GABA) A receptor, beta 2	505		NA			gamma-aminobutyric acid signaling pathway|synaptic transmission	cell junction|chloride channel complex|integral to plasma membrane|postsynaptic membrane	chloride channel activity|GABA-A receptor activity			breast(1)|central_nervous_system(1)|endometrium(2)|large_intestine(6)|liver(1)|lung(9)|soft_tissue(1)|upper_aerodigestive_tract(2)|urinary_tract(3)	26	Renal(175;0.00259)	Medulloblastoma(196;0.021)|all_neural(177;0.0463)	Kidney(164;7.83e-05)|KIRC - Kidney renal clear cell carcinoma(164;0.000525)		Ethchlorvynol(DB00189)|Flurazepam(DB00690)|Lorazepam(DB00186)|Midazolam(DB00683)	AGCCAATAGACGATGTTGAAG	0.453	NA	NA									NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA				0			NA	NA	NA	NA	NA						116	114	115	NA		NA	NA	5		NA											NA				160721114		2203	4300	6503	SO:0001583	missense			ENSG00000145864	HGNC:4082		Approved	uc003lys.1	NA	A8K115|A8K1A0|D1LYT0|D1LYT1|Q16323|Q4FZB2	ENST00000274547.2	37	CCDS4355.1	.	.	.	.	.	.	.	.	.	.	C	13.79	2.343048	0.41498	.	.	ENSG00000145864	ENST00000393959;ENST00000274547;ENST00000353437;ENST00000520240;ENST00000517901;ENST00000517547	D;D;D;D;D;D	0.86164	-2.08;-2.08;-1.77;-1.77;-1.77;-1.77	5.75	5.75	0.90469	Neurotransmitter-gated ion-channel transmembrane domain (2);	0.166320	0.52532	D	0.000068	T	0.79707	0.4492	N	0.16743	0.435	0.80722	D	1	B;B;B;B	0.27765	0.007;0.003;0.188;0.005	B;B;B;B	0.27500	0.008;0.013;0.08;0.012	T	0.74328	-0.3701	10	0.19147	T	0.46	.	19.9447	0.97177	0.0:1.0:0.0:0.0	.	307;404;505;467	B7Z279;E7EV50;P47870;P47870-1	.;.;GBRB2_HUMAN;.	I	505;505;467;467;404;307	ENSP00000377531:V505I;ENSP00000274547:V505I;ENSP00000274546:V467I;ENSP00000429320:V467I;ENSP00000430532:V404I;ENSP00000429750:V307I	ENSP00000274547:V505I	V	-	1	0	GABRB2	160653692	1.000000	0.71417	1.000000	0.80357	0.999000	0.98932	3.926000	0.56491	2.719000	0.93026	0.655000	0.94253	GTC	GABRB2-201	KNOWN	basic|CCDS	protein_coding	NA	protein_coding		36.497965	KEEP		-	39.39067	0.263158	15	42	---	---	---	---	1	1	106	295	0	366	16	45	0	57	2	TP
EGFR	1956	broad.mit.edu	37	7	55221765	55221765	+	Missense_Mutation	SNP	A	A	G			GBM-TCGA-32-1979-Tumor-SM-1Y49G	GBM-TCGA-32-1979-Normal-SM-1Y49B	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid	Somatic	Phase_I	WXS	none,targeted,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-32-1979-Tumor-SM-1Y49G	GBM-TCGA-32-1979-Normal-SM-1Y49B	g.chr7:55221765A>G	ENST00000275493.2	+	7	986	c.809A>G	c.(808-810)tAc>tGc	p.Y270C	EGFR_ENST00000442591.1_Missense_Mutation_p.Y270C|EGFR_ENST00000420316.2_Missense_Mutation_p.Y270C|EGFR_ENST00000455089.1_Missense_Mutation_p.Y225C|EGFR_ENST00000342916.3_Missense_Mutation_p.Y270C|EGFR_ENST00000344576.2_Missense_Mutation_p.Y270C|EGFR_ENST00000454757.2_Missense_Mutation_p.Y217C	NM_005228.3	NP_005219.2	P00533	EGFR_HUMAN	epidermal growth factor receptor	270		NA			activation of phospholipase A2 activity by calcium-mediated signaling|activation of phospholipase C activity|axon guidance|cell proliferation|cell-cell adhesion|negative regulation of apoptosis|negative regulation of epidermal growth factor receptor signaling pathway|ossification|positive regulation of catenin import into nucleus|positive regulation of cell migration|positive regulation of cyclin-dependent protein kinase activity involved in G1/S|positive regulation of epithelial cell proliferation|positive regulation of MAP kinase activity|positive regulation of nitric oxide biosynthetic process|positive regulation of phosphorylation|positive regulation of protein kinase B signaling cascade|protein autophosphorylation|protein insertion into membrane|regulation of nitric-oxide synthase activity|regulation of peptidyl-tyrosine phosphorylation|response to stress|response to UV-A	basolateral plasma membrane|endoplasmic reticulum membrane|endosome|extracellular space|Golgi membrane|integral to membrane|nuclear membrane|Shc-EGFR complex	actin filament binding|ATP binding|double-stranded DNA binding|epidermal growth factor receptor activity|identical protein binding|MAP/ERK kinase kinase activity|protein heterodimerization activity|protein phosphatase binding|receptor signaling protein tyrosine kinase activity			NS(2)|adrenal_gland(5)|biliary_tract(8)|bone(3)|breast(18)|central_nervous_system(106)|endometrium(26)|eye(3)|haematopoietic_and_lymphoid_tissue(9)|kidney(11)|large_intestine(85)|liver(2)|lung(13575)|oesophagus(21)|ovary(38)|pancreas(3)|peritoneum(11)|pleura(2)|prostate(35)|salivary_gland(11)|skin(9)|small_intestine(1)|soft_tissue(4)|stomach(41)|thymus(2)|thyroid(14)|upper_aerodigestive_tract(59)|urinary_tract(6)	14110	all_cancers(1;1.57e-46)|all_epithelial(1;5.62e-37)|Lung NSC(1;9.29e-25)|all_lung(1;4.39e-23)|Esophageal squamous(2;7.55e-08)|Breast(14;0.0318)		GBM - Glioblastoma multiforme(1;0)|all cancers(1;2.19e-314)|Lung(13;4.65e-05)|LUSC - Lung squamous cell carcinoma(13;0.000168)|STAD - Stomach adenocarcinoma(5;0.00164)|Epithelial(13;0.0607)		Cetuximab(DB00002)|Erlotinib(DB00530)|Gefitinib(DB00317)|Lapatinib(DB01259)|Lidocaine(DB00281)|Panitumumab(DB01269)|Trastuzumab(DB00072)	CTCATGCTCTACAACCCCACC	0.587	NA	8	"""A, O, Mis"""		"""glioma, NSCLC"""	NSCLC			Lung Cancer, Familial Clustering of	TCGA GBM(3;<1E-08)|TSP Lung(4;<1E-08)	NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA			yes	Dom	yes	Familial lung cancer	7	7p12.3-p12.1	1956	"""epidermal growth factor receptor (erythroblastic leukemia viral (v-erb-b) oncogene homolog, avian)"""		"""E, O"""	0			NA	NA	NA	NA	NA						210	165	180	NA		NA	NA	7		NA											NA				55221765		2203	4300	6503	SO:0001583	missense	Familial Cancer Database	incl. Hereditary Lung cancer, Hereditary Non-Small Cell Lung cancer	ENSG00000146648	HGNC:3236	NM_005228	Approved	uc003tqk.3	NA	O00688|O00732|P06268|Q14225|Q68GS5|Q92795|Q9BZS2|Q9GZX1|Q9H2C9|Q9H3C9|Q9UMD7|Q9UMD8|Q9UMG5	ENST00000275493.2	37	CCDS5514.1	.	.	.	.	.	.	.	.	.	.	A	25.7	4.661131	0.88154	.	.	ENSG00000146648	ENST00000455089;ENST00000342916;ENST00000395504;ENST00000344576;ENST00000420316;ENST00000275493;ENST00000442591;ENST00000454757;ENST00000533450	T;T;T;T;T;T;T	0.63255	-0.03;-0.03;-0.03;-0.03;-0.03;-0.03;-0.03	5.94	5.94	0.96194	Growth factor, receptor (1);Furin-like cysteine-rich domain (1);	0.000000	0.85682	D	0.000000	D	0.83801	0.5333	M	0.92555	3.32	0.80722	D	1	D;D;D;D;D	0.89917	1.0;1.0;1.0;1.0;1.0	D;D;D;D;D	0.97110	0.999;1.0;1.0;1.0;1.0	D	0.87710	0.2566	10	0.87932	D	0	.	15.2191	0.73296	1.0:0.0:0.0:0.0	.	225;270;270;270;270	Q504U8;P00533;P00533-3;P00533-4;P00533-2	.;EGFR_HUMAN;.;.;.	C	225;270;140;270;270;270;270;217;64	ENSP00000415559:Y225C;ENSP00000342376:Y270C;ENSP00000345973:Y270C;ENSP00000413843:Y270C;ENSP00000275493:Y270C;ENSP00000410031:Y270C;ENSP00000395243:Y217C	ENSP00000275493:Y270C	Y	+	2	0	EGFR	55189259	1.000000	0.71417	0.998000	0.56505	0.921000	0.55340	9.311000	0.96282	2.272000	0.75746	0.460000	0.39030	TAC	EGFR-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000251456.2	-40.105873	KEEP		+	315.892925	0.067465	124	1714	---	---	---	---	1	0.9999995	59	860	11	700	142	1939	0	71	25	TP
SEMG1	6406	broad.mit.edu	37	20	43837052	43837052	+	Missense_Mutation	SNP	C	C	T			GBM-TCGA-32-1979-Tumor-SM-1Y49G	GBM-TCGA-32-1979-Normal-SM-1Y49B	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid	Somatic	Phase_I	WXS	none,targeted,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-32-1979-Tumor-SM-1Y49G	GBM-TCGA-32-1979-Normal-SM-1Y49B	g.chr20:43837052C>T	ENST00000372781.3	+	2	1171	c.1114C>T	c.(1114-1116)Cgc>Tgc	p.R372C	SEMG1_ENST00000244069.6_Missense_Mutation_p.R312C	NM_003007.3	NP_002998.1			semenogelin I	NA		NA								cervix(1)|endometrium(2)|kidney(3)|large_intestine(3)|liver(1)|lung(12)|prostate(1)|skin(6)|stomach(2)|urinary_tract(1)	32		Myeloproliferative disorder(115;0.0122)				TGTATCCCAACGCAGTATTTA	0.418	NA	NA									NA	NA	A	1	5e-04	0.002	NA	2184	NA	1	,	,	NA	3e-04	NA	NA	NA	5e-04	1	EXOME	NA	NA	4e-04	SNP						NA		NA				0			NA	NA	NA	NA	NA						77	71	73	NA		NA	NA	20		NA											NA				43837052		2203	4300	6503	SO:0001583	missense			ENSG00000124233	HGNC:10742	NM_003007	Approved		NA		ENST00000372781.3	37	CCDS13345.1	1	4.578754578754579E-4	1	0.0020325203252032522	0	0.0	0	0.0	0	0.0	A	11.44	1.640642	0.29157	.	.	ENSG00000124233	ENST00000244069;ENST00000372781	T;T	0.06528	3.29;3.29	0.951	-1.9	0.07665	.	.	.	.	.	T	0.02455	0.0075	N	0.08118	0	0.09310	N	1	B;B	0.27498	0.18;0.109	B;B	0.15052	0.01;0.012	T	0.39603	-0.9606	9	0.72032	D	0.01	.	0.297	0.00267	0.2228:0.2395:0.2981:0.2396	.	312;372	P04279-2;P04279	.;SEMG1_HUMAN	C	312;372	ENSP00000244069:R312C;ENSP00000361867:R372C	ENSP00000244069:R312C	R	+	1	0	SEMG1	43270466	0.000000	0.05858	0.001000	0.08648	0.002000	0.02628	-0.965000	0.03829	-2.064000	0.00888	-1.625000	0.00788	CGC	SEMG1-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000079416.3	52.101702	KEEP		+	54.172844	0.306452	19	43	---	---	---	---	1	1	48	129	0	177	20	48	0	72	2	TP
